DrugPatentWatch Database Preview
Details for Patent: 7,368,102
Which drugs does patent 7,368,102 protect, and when does it expire?
Patent 7,368,102 protects TOBI PODHALER and is included in one NDA.
This patent has fifteen patent family members in fourteen countries.
This patent has fifteen patent family members in fourteen countries.
Summary for Patent: 7,368,102
| Title: | Pulmonary delivery of aminoglycosides |
| Abstract: | The present invention is directed to the administration of aminoglycosides. In particular, the present invention is directed to compositions and methods for the pulmonary administration of aminoglycosides. According to a preferred embodiment, compositions and methods are provided for the localized treatment of respiratory infections. |
| Inventor(s): | Tarara; Thomas E. (Burlingame, CA), Weers; Jeffry G. (Half Moon Bay, CA), Venthoye; Geraldine (Foster City, CA) |
| Assignee: | Nektar Therapeutics (San Carlos, CA) |
| Application Number: | 10/327,510 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Dosage form; Delivery; Use; Device; |
Drugs Protected by US Patent 7,368,102
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | TOBI PODHALER | tobramycin | POWDER;INHALATION | 201688-001 | Mar 22, 2013 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | TREATMENT OF CYSTIC FIBROSIS PATIENTS WITH PSEUDOMONAS AERUGINOSA | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
Non-Orange Book US Patents Family Members for Patent 7,368,102
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 8,715,623 | Pulmonary delivery of aminoglycoside | ➤ Try a Free Trial |
| 9,421,166 | Pulmonary delivery of aminoglycoside | ➤ Try a Free Trial |
| Patent No. | Title | Estimated Patent Expiration |
International Patents Family Members for US Patent 7,368,102
| Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 508735 | ➤ Try a Free Trial | |||
| Australia | 2002361897 | ➤ Try a Free Trial | |||
| Canada | 2468958 | ➤ Try a Free Trial | |||
| Cyprus | 1112560 | ➤ Try a Free Trial | |||
| Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
